All Clinical Trials
View all active clinical trials around the US.
Nivolumab As An Adjunctive Therapy In Relapsed Refractory Multiple Myeloma Patients With Sub-Optimal Response To Idecabtagene Vicleucel
NIVOLUMAB POST TREATMENT WITH IDE-CEL
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
AMYLOIDOSIS SCREENING
Untreated / Newly Diagnosed Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have been newly diagnosed or have not yet received treatment.
Early Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
Nivolumab As An Adjunctive Therapy In Relapsed Refractory Multiple Myeloma Patients With Sub-Optimal Response To Idecabtagene Vicleucel
NIVOLUMAB POST TREATMENT WITH IDE-CEL
Late Relapse Multiple Myeloma
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
Nivolumab As An Adjunctive Therapy In Relapsed Refractory Multiple Myeloma Patients With Sub-Optimal Response To Idecabtagene Vicleucel
NIVOLUMAB POST TREATMENT WITH IDE-CEL
Smoldering Myeloma
The following is a listing of clinical trials for patients with Smoldering Myeloma.
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
AMYLOIDOSIS SCREENING
Monoclonal Gammopathy of Undetermined Significance (MGUS)
No active clinical trials